Today’s top gainers include the company Novo Nordisk A/S (NYSE:NVO) which is in the industry Drug Manufacturers – Other, gaining 1.24% today. In the last week its performance is 1.52%, and -12.23% for the past quarter. Currently, Novo Nordisk A/S, NVO has a target price of 57, so today’s gain of 1.24% is a significant step towards its target price. The GAP today is therefore 2.30%.
Novo Nordisk A/S (NYSE:NVO), has a market cap of 94505.86, and is based in Denmark. Insider ownership is at 26.40%, and institutional ownership is 10.00%.
At the current price of 47.46, it has a dividend yield of 3.01%, and its target price is 57. This is with a profit margin of 32.70%, and total debt/equity of 0.01. Novo Nordisk A/S (NYSE:NVO) has a P/E of 21.74, as well as a forward P/E of 19.34.
With a current EPS of 2.16, and a forecasted EPS growth for next year at 6.78%,Novo Nordisk A/S (NYSE:NVO) has had a EPS growth for the past five years at 22.40%. For the next five years EPS growth is projected to be 10.60%.
Performance for the year is -14.95%. Since its IPO date on 1/4/1982, the total performance to date is -17.07%.
Volume today for Novo Nordisk A/S (NYSE:NVO), is 2233821, while its average volume is 2013.03. Whilst the total gain today was 1.24%, it did have a day high of -16.54%.
Volatility for this week has been at 0.99%, and 1.27% for the month. The 52-week low for Novo Nordisk A/S, NVO has been 5.61%, while the 52-week-high has reached -17.35%.
Looking at its return of investments, which is 85.00%, and its return on assets is 41.50%. Novo Nordisk A/S (NYSE:NVO) has an operating margin of 43.40%. With a sales growth of 1.50% quarter over quarter. Bearing in mind that Novo Nordisk A/S, NVO is in the sector Healthcare, its long-term debt/equity is 0, and has a current ratio of 1.3 and 0.9 for quick ratio.
So what is the value of Novo Nordisk A/S? Well its PEG is 2.05, and the P/S is 5.61, along with a P/B of 18.31. Meanwhile it has a p/cash of 40.7.